Home » Topics » BioWorld Science

BioWorld Science
RSS

Chugai MSD to market OTC famotidine in Japan

June 10, 1997

Encouraging interim data from Avicidin trial

June 10, 1997

Protein repair enzyme may be involved in seizures/neurodegenerative diseases

June 10, 1997

Peptidomimetic inhibitors of fungal NMT prepared by Searle

June 10, 1997

Synthelabo and Praecis collaborate on prostate cancer product

June 10, 1997

Guilford's Parkinson's disease diagnostic safe and effective in phase IIb study

June 10, 1997

Micrologix Biotech enhancin restores activity of vancomycin

June 10, 1997

Company profile: Trilex

June 10, 1997

Introduction of Rescriptor in late June

June 10, 1997

NN-304, a long-acting insulin analogue in preclinical testing

June 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...